On 2025-05-08, Cullinan Therapeutics, Inc. (CGEM) announced earnings per share of $-0.74 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.78.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.77 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.78 | $-0.74 |
| 2025-02-27 | 2024-12-31 | $-0.75 | $-0.73 |
| 2024-11-07 | 2024-09-30 | $-0.78 | $-0.69 |
| 2024-08-08 | 2024-06-30 | $-0.73 | $-0.75 |
| 2024-05-15 | 2024-03-31 | $-0.90 | $-0.86 |
| 2024-03-14 | 2023-12-31 | $-0.96 | $-0.54 |
| 2023-11-08 | 2023-09-30 | $-0.91 | $-0.91 |
| 2023-08-10 | 2023-06-30 | $-0.99 | $-0.82 |
| 2023-05-11 | 2023-03-31 | $-0.84 | $-1.42 |
| 2023-03-09 | 2022-12-31 | $-0.65 | $-0.59 |
| 2022-11-14 | 2022-09-30 | $-0.97 | $-0.54 |
| 2022-08-10 | 2022-06-30 | $5.47 | $-2.20 |
| 2022-05-16 | 2022-03-31 | $-0.61 | $-0.27 |
| 2022-03-17 | 2021-12-31 | $-0.47 | $-0.74 |
| 2021-11-09 | 2021-09-30 | $-0.42 | $-0.40 |
| 2021-08-10 | 2021-06-30 | $-0.42 | $-0.36 |
| 2021-05-14 | 2021-03-31 | $0.07 | $0.00 |